Cambridge Investment Research Advisors’s Essent Group ESNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,663
Closed -$563K 3976
2025
Q4
$563K Buy
8,663
+53
+0.6% +$3.29K ﹤0.01% 2598
2025
Q3
$547K Sell
8,610
-101
-1% -$6.14K ﹤0.01% 2589
2025
Q2
$529K Buy
8,711
+962
+12% +$55.4K ﹤0.01% 2499
2025
Q1
$447K Sell
7,749
-214
-3% -$12.1K ﹤0.01% 2545
2024
Q4
$433K Buy
+7,963
New +$462K ﹤0.01% 2543
2023
Q3
Sell
-4,534
Closed -$212K 3177
2023
Q2
$212K Buy
+4,534
New +$197K ﹤0.01% 2825
2017
Q1
Sell
-14,249
Closed -$461K 1776
2016
Q4
$461K Buy
+14,249
New +$419K 0.01% 1055

Other funds holding ESNT

Cambridge Investment Research Advisors's ESNT Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Essent Group (ESNT) in Q1 2026, closing a stake of 8,663 shares — an estimated $563K sold.

Cambridge Investment Research Advisors first reported a position in ESNT in Q4 2016 and held it in 7 quarters. The position peaked at $563K in Q4 2025. 369 funds tracked by Wall St. Rank hold ESNT as of Q1 2026.

  • Cambridge Investment Research Advisors reported no remaining Essent Group position as of Q1 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 8,663 Essent Group shares in Q1 2026, an estimated $563K.
  • Cambridge Investment Research Advisors first reported a position in Essent Group in Q4 2016 and held it in 7 quarters.
  • Cambridge Investment Research Advisors's Essent Group position peaked at $563K in Q4 2025.
  • 369 funds tracked by Wall St. Rank held Essent Group as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.